Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease
Babak Andi, D. Kumaran, Dale F. Kreitler, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro)
Ali Ebrahim, Blake T. Riley, D. Kumaran, et al.
IUCrJ (2022) Vol. 9, Iss. 5, pp. 682-694
Open Access | Times Cited: 43
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Michael Westberg, Yichi Su, Xinzhi Zou, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Open Access | Times Cited: 12
Electrochemical synthesis of peptide aldehydes via C‒N bond cleavage of cyclic amines
Xinyue Fang, Yong Zeng, Yawen Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
Mikhail A. Hameedi, Érica T. Prates, Michael R. Garvin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Targeting cellular cathepsins inhibits hepatitis E virus entry
Mara Klöhn, Thomas Burkard, Juliana Janzen, et al.
Hepatology (2024) Vol. 80, Iss. 5, pp. 1239-1251
Open Access | Times Cited: 5
Nucleoside antiviral agents with atypical structures and new targets
Hui Xu, B. Li, Kai Tang, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130110-130110
Closed Access
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
Karen Anbro Gammeltoft, Yuyong Zhou, Line A. Ryberg, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1970-1970
Open Access | Times Cited: 12
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 4
Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity
Daniel W. Carney, Abba E. Leffler, Jeffrey A. Bell, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117577-117577
Open Access | Times Cited: 2
In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro
Noha A. Saleh
3 Biotech (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 7
Structure-Based Discovery of Thiosemicarbazones As SARS-CoV-2 Main Protease Inhibitors
Vinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 959-985
Closed Access | Times Cited: 7
Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds
Trung Hai Nguyen, Quynh Mai Thai, Phạm Minh Quân, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 553-561
Open Access | Times Cited: 6
Validation of X-ray Crystal Structure Ensemble Representations of SARS-CoV-2 Main Protease by Solution NMR Residual Dipolar Couplings
Yang Shen, Angus J. Robertson, Ad Bax
Journal of Molecular Biology (2023) Vol. 435, Iss. 11, pp. 168067-168067
Open Access | Times Cited: 5
Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery
Liang Xu, Ru Chen, Jie Liu, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103727-103727
Closed Access | Times Cited: 5
Eliminating the missing cone challenge through innovative approaches
Cody Gillman, Guanhong Bu, Emma Danelius, et al.
Journal of Structural Biology X (2024) Vol. 9, pp. 100102-100102
Open Access | Times Cited: 1
Unsupervised deep learning for molecular dynamics simulations: a novel analysis of protein–ligand interactions in SARS-CoV-2 Mpro
Jessica Mustali, Ikki Yasuda, Yoshinori Hirano, et al.
RSC Advances (2023) Vol. 13, Iss. 48, pp. 34249-34261
Open Access | Times Cited: 4
In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease
Yuri Alves de Oliveira Só, Kelton Silva Bezerra, Ricardo Gargano, et al.
(2024)
Open Access | Times Cited: 1
In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease
Yuri Alves de Oliveira Só, Katyanna Sales Bezerra, Ricardo Gargano, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 755-755
Open Access | Times Cited: 1
Eliminating the missing cone challenge through innovative approaches
Cody Gillman, Guanhong Bu, Emma Danelius, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multimolecular feature-based machine learning: system biology enhanced RF-QSAR modeling for the efficient prediction of the inhibitory potential of diverse SARS CoV-2 3CL Protease inhibitors
Ajay Manaithiya, Ratul Bhowmik, Rajarshi Ray, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Peptide Aldehydes Incorporating Thiazol-4-yl Alanine Are Potent In Vitro Inhibitors of SARS-CoV-2 Main Protease
Jenson R. Feys, Kyle C. Edwards, Michael Joyce, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 2046-2052
Closed Access
Alpha-helices as alignment reporters in residual dipolar coupling analysis of proteins
Yang Shen, Melody Smith, John M. Louis, et al.
Journal of Biomolecular NMR (2024)
Open Access
In silico analysis: Fulleropyrrolidine derivatives against HIV-PR mutants and SARS-CoV-2 Mpro
Noha A. Saleh
Computational and Mathematical Biophysics (2024) Vol. 12, Iss. 1
Open Access
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
Modeling and Study of Anti-coronavirus Activity of 6,7-Dimethoxyquinazoline-4(3H)-one Derivatives in Relation to SARS-COV-2 by in silico and in vitro Methods
A. Chiriapkin, I. N. Tyurenkov, И. П. Кодониди, et al.
Bulletin of Science and Practice (2023), Iss. 8, pp. 58-68
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top